Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate

Santoro A;Castagna L;Magagnoli M;Bramanti S;Mariotti J;Mazza R;Morello L;Ricci F;Sarina B;De Philippis C;Sica S;Rodari M;Sollini M;Kirienko M;Giordano L;Chiti A;Corradini P;Carlo-Stella C

2018-01-01